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Abstract
Periodontitis is a highly complex and multi-factorial disease. This review summarizes some 
immunological factors involved in the development and control of this oral disease, such 
as: the participation of inflammatory cells in local inflammation, the synthesis of chemotaxis 
proteins with activation of the complement system and a range of antimicrobial peptides, such 
as defensins, cathelicidin and saposins. The integration of pathogen-associated molecular 
patterns (PAMPs) from microorganisms with their surface receptors in the immune cells, induces 
the production of several cytokines and chemokines that presents either a pro- and/or anti-
inflammatory role by stimulating the secretion of a great variety of antibody subtypes and the 
activation of mechanisms of controlling the disease, such as the regulatory T cells. Although 
several studies have tried to clarify some of the immune mechanisms involved in periodontal 
disease, more studies must be conducted to understand its development and progression 
and consequently to discover new alternatives for the prevention and treatment of this severe 
inflammatory disease.
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Resumo
A periodontite é uma doença altamente complexa e multifatorial. Esta breve revisão reúne 
alguns fatores imunológicos envolvidos no desenvolvimento e controle desta doença oral, 
tais como: a participação de células inflamatórias no local da inflamação, a síntese de 
proteínas quimiotáticas através da ativação do sistema complemento e a presença de alguns 
dos peptídeos antimicrobianos, como defensinas, catelicidinas e saposinas. A interação de 
padrões moleculares associados à patógenos (PAMPs) de microrganismos com seus receptores 
de superfície, em células imunológicas, induz a produção de várias citocinas e quimiocinas 
que apresentam função pró- e/ou anti-inflamatória estimulando a secreção de uma grande 
variedade de subtipos de anticorpos e a ativação de mecanismos de controle da doença, como 
as células T reguladoras. Embora vários trabalhos tentem esclarecer alguns dos mecanismos 
imunológicos envolvidos na doença periodontal, estudos adicionais são necessários para 
ampliar conhecimentos sobre o desenvolvimento, a progressão e, consequentemente, para se 
descobrir novas alternativas de prevenção e tratamento desta grave doença inflamatória.
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Introduction
Periodontal disease is a chronic bacterial infection that affects 
the gingiva and bone that supports the teeth. This chronic 
inflammatory disease results from the response to bacteria 
in dental biofilm and may remain confined to the gingival 
tissues with minimal tissue alterations or this disease may 
progress to extreme periodontal destruction with the loss of 
attachment and alveolar bone. In addition to the presence of 
periodontopathogens; such as Porphyromonas gingivalis, 
Aggregatibacter actinomycetemcomitans and Tannerella 
forsythia;  genetic  and  environmental  factors  seem  to 
increase the susceptibility of some individuals in developing 
this severe inflammatory disease (1) (Fig. 1). Therefore, 
there is general support for this concept of periodontal 
disease. It is also well recognized that the presence of only 
pathogenic bacteria is insufficient to cause periodontitis. 
Progression of this disease occurs due to a combination 
of  factors,  including  the  presence  of  periodontopathic 
bacteria, high levels of proinflammatory cytokines, matrix 
metalloproteinases  (MMPs),  prostaglandin  E2  (PGE2), 
low levels of anti-inflammatory cytokines including inter- 
leukin-10 (IL-10), transforming growth factor (TGF-β) and 
tissue inhibitors of MMPs (TIMPs) (2,3). However, the 
immune response initiated by periodontal disease seems to 
be much broader. Therefore, this review summarizes some 
immune mechanisms involved in periodontal disease.
Innate immune response in periodontal disease
Histological  examination  of  gingivitis  or  periodontitis 
lesions  reveals  that  the  polymorphonuclear  leukocyte 
(PMN) appears to play a key role in the maintenance of 
the periodontal health (3). These cells are present in the 
junctional epithelium in large numbers and appear to wall 
off the underlying tissues from the bacterial biofilm. The 
presence of these PMNs is the result of the existence or 
generation of chemotactic factors in the gingival sulcus 
and underlying tissues (4). Extra-oral infections and early 
severe forms of periodontitis frequently affect patients with 
diseases such as leukocyte adhesion deficiency and chronic 
or cyclic neutropenia. Molecular defects in PMNs, with a 
variety of functional consequences, result in accelerated 
periodontitis. The failure of PMNs to transmigrate into the 
endothelium results in an increase on the inflammatory 
response  and  reduces  the  protective  response  against 
periodontal pathogens (5).
Periodontal  epithelium  provides  a  physical  barrier  to 
infection and has an active role in the innate host defense, 
because the epithelial cells are in constant contact with 
bacterial products (6). In the presence of active disease, 
the epithelial migration causes a deep periodontal pocket 
resulting in bacterial invasion, inflammation and destruction 
of the connective tissue, with subsequent bone loss and 
possible tooth loss. The epithelium can participate in the 
infection by signaling further innate and acquired immune 
responses (Fig. 2). Epithelial cells may also respond to 
bacteria by increasing their proliferation, by altering their 
Fig. 1. Factors involved in the severity of periodontitis.
Fig. 2. Some mechanisms involved in periodontal disease. 
(A)  The  intact  epithelial  barriers  may  delay  the  entry  of 
periodontopathogenic  bacteria  and  their  products  in  oral 
tissues, maintaining the health of periodontum (B) Disruption 
of epithelial barriers allows the entry of periodontopathogenic 
bacteria and their products in the tissues host. In response, cells 
of the innate and adaptive immunity are activated and produce 
LL-37, defensins, saposins, cytokines and chemokines against 
invasors agents. PMN, polimorphonuclear cells.
cell signaling events, and by changing the cell differentiation 
and cell death and altering tissue homeostasis. Langerhans 
cells and dendritic cells of bone marrow origin that are 
located within the epithelium are a connecting link with 
acquired immunity. Langerhans cells in the epidermis and 
oral mucosa are responsible for communication with the 
immune system (7). 302  Rev. odonto ciênc. 2010;25(3):300-305
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It is now recognized that epithelia throughout the body 
produces a diverse range of antimicrobial peptides in at 
least four families (α-defensins, β-defensins, cathelicidins, 
saposins) that have been found in humans (8). These peptides 
have  been  associated  with  saliva  or  are  present  in  the 
dentogingival junction region. The oral sulcular pocket and 
junctional epithelia of the gingival are all associated with the 
expression of defensin, more specifically β-defensins hBD-1, 
hBD-2 and hBD-3 (6). The integrity of the epithelial barrier 
is specifically disrupted by different microbial pathogens 
that attack cell-cell junctions and thereby dissociate cells 
from each other (9). Families of natural antibiotic peptides 
or proteins are expressed in epithelia and by neutrophils. 
These proteins have an activity against Gram-positive and 
Gram-negative bacteria, as well as against yeast and some 
viruses. These antimicrobial peptides function by associating 
with the anionic microbial surface, then aggregating to 
form pores or disrupt the microbial membranes, although 
new evidence potentially suggests additional cytoplasmic   
targets (10). These peptides complement the antimicrobial 
factors of saliva, such as the histatins, lyzozyme, and salivary 
immunoglobulins, having a specific role in the innate host 
defense in response to an infection (4).
The α-defensins and cathelicidin LL37 are proteolytically 
active peptides, present in high levels in neutrophils that 
migrate through the junctional epithelium to the gingival 
sulcus (8). Some investigators believe that the primary role 
of β-defensins may be to signal other innate and acquired 
immune responses while LL37 and α-defensins may be most 
important for their antimicrobial properties in the gingival 
sulcus (11). These peptides are capable of activating the 
classical complement pathway and appear to upregulate IL-8 
production by epithelial cells, which may enhance neutrophil 
recruitment to the site of infection (12).
Innate immunity has a considerable ability to recognize 
bacteria as non-self agents because these microorganisms 
present PAMPs in the bacterial wall, which are recognized 
by pattern recognition receptors (PRRs) on immune cell 
surfaces. PAMPs are invariant and represent conserved 
molecular patterns that are essential for microbial survival. 
They are found in bacterial lipopeptides, peptidioglycan, 
flagellin and DNA, with others that are specific either 
for Gram-negative (lipopolysaccharide (LPS)) or Gram-
positive (lipoteichoic acid) bacteria (4,13). The toll-like 
receptor (TLR) family is the best characterized class of 
PRRs and detects multiple PAMPs (14,15). Mammalian 
TLRs comprise a large family that consists of at least 11 
members. TLRs 1-9 are conserved between humans and 
mice, and each of these recognizes a unique molecular 
pattern  associated  with  different  classes  of  pathogens.   
TLR4 recognizes LPS, which is a major cell wall component 
of Gram-negative bacteria (16). Reports have suggested 
that TLR2 may recognize several atypical types of LPS 
from Leptospira interrogans and P. gingivalis. TLR2 and 
TLR4  recognize  bacterial  components  that  are  mainly 
present in the bacterial cell membrane. TLR5 recognizes 
flagellin, which is a protein component of the flagella 
extending out from the outer membrane of Gram-negative 
bacteria. TLR9 recognizes unmethylated CpG motifs that 
are found in the bacterial genomic DNA and also in viral   
DNA (15,17). 
TLRs are expressed on a variety of cells, including both 
lymphoid and nonlymphoid cells, and on various epithelial 
surfaces, including dendritic cells. TLR2, TLR3, TLR4 and 
TLR5 are differentially expressed on oral, bronchial and 
gastrointestinal epithelia. Pathogen recognition by TLRs 
expressed from epithelial cells leads to the production of 
cytokines,  chemokines  and  antimicrobial  peptides  that 
induce  the  recruitment  of  more  inflammatory  cells  to 
the infected sites (4,18). The interactions of TLRs with 
commensal microorganisms are also required to maintain 
epithelial homeostasis (19). 
Bacterial LPS can subsequently interact with macrophage 
or dendritic cell receptors, including CD14 and TLRs, to 
stimulate the production of inflammatory cytokines and 
other  mediators  (4).  Some  authors  have  indicated  that 
the  model  of  tissue  destruction,  which  focuses  on  the 
production of IL-1 as a key mediator of periodontal tissue 
destruction, includes the stimulation of collagenolytic and 
bone-destructive agents, such as MMPs and PGE2 (4,20). It 
is important to note that cells other than macrophages are 
present in periodontal lesions (such as fibroblasts) which 
also produce inflammatory cytokines, lipid mediators, and 
MMPs and are likely to participate in the accumulation of 
these molecules (15,21,22).
Adaptive immune response in periodontal disease
The adaptative immune response is activated when the 
epithelial barrier, with its antimicrobial peptides and other 
components  of  innate  systems,  are  breached  (Fig.  2). 
Cytokines or interleukins are integral with this response 
and represent intercellular messengers (23,24). In agreement 
with Gemmell et al. (2), the immune response to infection is 
regulated by the balance between T helper (Th) 1 and Th2 
cytokines. The differentiation of Th1 and Th2 T cell subsets 
is determined by a number of factors, including the antigen 
itself, antigen dose, route of administration, nature of the 
antigen-presenting cell and co-stimulatory molecules. IL-18, 
as a cofactor with IL-12, is recognized as a cytokine that is able 
to enhance the maturation of naïve T cells to Th1 cells (25). 
However, there is not a consensus about the Th1/Th2 immune 
response in periodontal disease. Some studies have shown 
a decrease in Th1 responses in periodontitis, while others 
have shown increased Th2 responses. However, other studies 
have indicated a dominance of the Th1 response over the 
Th2 response, with other studies showing a predominance of 
Th0 cells in periodontitis (25,26). This variable knowledge 
confuses the current understanding of the development and 
control of periodontitis.
By the end of the 19th century, studies recognized that 
diapedesis  was  a  fundamental  mechanism  of  the  host 
defense,  as  this  mechanism  involved  the  process  of 
leukocyte emigration. Leukocyte invasion of tissues can 
be induced by several substances, including IL-1, tumor   Rev. odonto ciênc. 2010;25(3):300-305  303
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necrosis factor-α (TNF-α), and bacterial LPS when injected 
in vivo (27). However, in 1996, other chemokines (from 
chemotactic cytokines) have raised considerable interest for 
their selective recruitment and activation of leucocytes (27). 
Chemokines are a large family of small proteins that are 
structurally similar to heparin-binding proteins, which are 
classified into 4 subfamilies according to the configuration of 
cysteine residues near the N-terminus, depending on whether 
the first 2 cysteines are separated (CXC, CX3C) or not   
(CC, C) by an intervening amino acid (28). Chemokine 
receptors  are  named  according  to  the  family  of  their 
ligands, with the two major subfamilies designated CCR 
and CXCR. These are synthesized by several cell types, 
including endothelial, epithelial, and stromal cells, such as 
fibroblasts, mast and bone cells, as well as leukocytes (27). 
Interestingly, in addition to the crucial role of chemokines 
in cell trafficking, chemokine messengers initiate signal 
transduction events leading to other biological processes, 
such as angiogenesis, cell proliferation, apoptosis, tumor 
metastasis, and host defense (28).
On the other hand, related to periodontal disease, Boyle 
et  al.  (29)  suggested  that  the  integrity  of  bone  tissues 
depends on the maintenance of an equilibrium between 
bone resorption by osteoclasts and bone deposition by 
osteoblasts. The major regulatory mechanism of osteoclast 
activity seems to be performed by members of the TNF 
family of receptors, RANK (receptor activator of nuclear 
factor-β), osteoprotegerin (OPG), and the RANK ligand 
(RANKL). RANK is expressed on osteoclastic precursors 
and on mature osteoclasts, while RANKL, a transmembrane 
protein,  is  expressed  particularly  on  osteoblasts  under 
homeostatic conditions. Interactions between RANK and 
RANKL are required for the differentiation and activation 
of osteoclasts, an event regulated by OPG, which strongly 
inhibits bone resorption by preventing RANK-RANKL 
engagement (29). Interestingly, RANKL also induces the 
production  of  some  substances,  such  as  MCP-1/CCL2, 
which could contribute to bone resorption (30). Osteoblasts 
are found to express several chemokines receptors during 
synthesis, which can modulate their function through the 
binding of chemokines. Additionally, an osteoclast can 
produce  important  chemokines  which  are  involved  in 
the recruitment of neutrophils and different lymphocyte 
subsets, suggesting an interesting role for osteoblasts in the 
development of the inflammatory immune reaction (31). 
Furthermore,  the  production  of  chemokines,  with  the 
consequent chemoattraction of inflammatory cells in the 
bone environment, may contribute to the disruption of bone 
homeostasis, resulting in tissue destruction (32). Therefore, 
the  subsets  of  leucocytes  the  form  the  inflammatory 
infiltrate, Th1 or Th2 cells, can determine the level of bone 
destruction/deposition because these population cells differ 
in their migratory properties (33).
Both T and B cells are present in periodontal disease tissues. 
The infiltrate in the periodontal lesion consists of lymphocytes, 
macrophages, neutrophils and mast cells that migrate to the 
tissue, guided by the different concentrations of chemokines 
and cytokines. INF-γ (Th1 response) produced by T cells 
would enhance the phagocytic activity of macrophages and 
neutrophils and contain the infection. However, if there is 
IL-4 production (Th2 response), B cells are activated and 
start antibody production (34). Studies have verified the 
strong antibody responses against specific bacterial antigens, 
such as the LPS or leukotoxin of A. actinomycetemcomitans 
and the LPS or hemaglutinin of P. gingivalis, which were 
associated with less severe disease in patients with aggressive 
or chronic periodontitis (4,35,36). The protective role of local 
antibody production, as detected by elevated concentrations 
of gingival crevice fluid antibodies, is unclear (37). Some 
researchers have suggested that, in the chronic phase of 
the disease, the antibody response is generally protective, 
facilitating bacterial clearance and arresting the progression 
of the disease (38).
Regulatory T cells
Beyond Th1 and Th2 subpopulations of T cells, which 
determine the response to infection based on the cytokine 
pattern induced, a distinct subset of CD4+ T cells, called 
regulatory T cells, has received intense focus since last 
decade, due to their role in the regulatory network that 
controls immune responses. Three distinct regulatory T 
(Treg) cells have been described. Naturally occurring Treg 
cells, CD4+and CD25+ T cells, originate directly from the 
thymus during the early stages of fetal and neonatal T cell 
development. These cells make up approximately 5-10% 
of the peripheral T cell pool and constituently express 
several suppressing mediators, such as CD25 (α chain IL-2 
receptor), glucocorticoid induced TNF-R (GITR), cytotoxic 
T lymphocyte Ag-4 (CTLA-4), CD103 and the transcription 
factor Foxp3 (39).
In contrast to the intrathymic natural Treg cells, inducible 
Treg cells are generated in the periphery, after a pathogen 
is eliminated to prevent secondary autoimmunity. Their 
generation is dependent on peripheral factors, such as the 
maturation and type of the stimulating antigen-presenting 
cells (APC) (40), availability of cytokines such as TGF-β (41) 
and the presence of low-dose antigens (42). Finally, inducible 
Treg cells corresponds to Tr1 and Th3 regulatory T cells. Tr1 
cells are characterized by a pattern of cytokine production, 
producing high levels of IL-10 and TGF-β and IL-5, low 
amounts of IFN-γ and IL-2, and no IL-4 (43), and have 
been shown to prevent the development of Th1-mediated 
autoimmune disease and suppress the immune response to 
pathogens, tumors and alloantigens (44). The Th3 subset 
of regulatory T cells is described by primarily secreting 
TGF-β and IL-1 inhibitor, both of which have an important 
role in immune regulation (39,45). Actually, the presence 
of regulatory T cells has been related to several immune 
responses,  such  as  allergy,  asthma,  atopic  dermatitis,   
rhinitis  (46),  inflammatory  dermatoses,  i.e.  spongiotic 
dermatitis, psoriasis, lichen planus and leishmaniasis (47) 
and recently has been described in participating with Treg 
cells in periodontal disease (48-50).304  Rev. odonto ciênc. 2010;25(3):300-305
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As mentioned previously, inflammatory periodontitis lesions 
are caused by a group of periodontopathic bacteria and are 
characterized by large numbers of B cells and plasma cells 
together with a significant number of T cells and different 
concentrations of Th1 and Th2 cytokines (23,24). Among the 
subsets of T cells, the participation of regulatory T cells 
in  periodontal  disease  has  been  largely  studied.  Some 
search showed that identifying CD4+, CD25+, CTLA-4+, 
mRNA as a transcription factor Foxp3 and several cytokines 
and chemokines (such as IL-10, IL-4, IL-17, TGF-β and 
RANKL markers of Treg cells in periodontal lesions (46). 
Additionally, the increased frequency of Treg cells were 
evidenced by Cardoso et al in inflammatory infiltrate of 
gingival  tissues  from  patients  with  chronic  periodontal   
disease (50) strengthening the idea to involvement of cells 
type  in  pathogenesis  of  periodontal  disease.  However, 
the accurate function of Treg cells in the development of 
periodontal disease remains unknown and the understanding 
of  the  role  of  population  cells  will  impact  the  current 
understanding and treatment of periodontal disease.
Conclusions
In this review, a brief introduction of periodontal disease, 
focusing  on  the  important  participation  of  periodonto- 
pathogenic  bacteria  associated  with  proinflammatory, 
environmental  and  genetic  factors  was  made.  It  was 
noted  that  some  individuals  that  are  more  susceptible 
to this oral pathology present with periodontal disease. 
The complex immune mechanism, including innate and 
adaptive systems, which may interfere in the development 
and progression of the periodontal disease, was described. 
However, there was no consensus regarding the pattern of 
the immune response in controlling this oral disease, even 
if the response generated may have a role in controlling 
or exacerbating the clinical situation observed in patients 
affected  by  periodontitis. Thus,  although  many  studies 
have been conducted to understand this process, many gaps 
still need to be clarified in order to utilize this knowledge 
in the comprehension of the development of periodontal   
disease.
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